Iterum Therapeutics Plc (NASDAQ: ITRM)
$1.52
(-1.9%)
-$0.03
Price as of April 25, 2024, 9:30 a.m. ET
Iterum Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Iterum Therapeutics Plc Company Info
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
News & Analysis
Featured Article
Why Iterum Therapeutics Stock Is Crashing Today
The company received disappointing news from the FDA.
Keith Speights | Jul 2, 2021
Featured Article
Why Iterum Therapeutics Stock Soared Today
The FDA gave the company some good news.
Keith Speights | May 28, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.